Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib

Metastatic colorectal cancer is frequently associated with poor clinical conditions that may limit therapeutic options. Regorafenib is a small molecule approved for the treatment of metastatic colorectal cancer, but it is hampered by significative toxicities. Moreover, only a relatively limited numb...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbona, Andrea, Ricci, Vincenzo, Paccagnella, Matteo, Granetto, Cristina, Ruatta, Fiorella, Cauchi, Carolina, Galizia, Danilo, Ghidini, Michele, Denaro, Nerina, Merlano, Marco Carlo, Garrone, Ornella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959285/
https://www.ncbi.nlm.nih.gov/pubmed/36851213
http://dx.doi.org/10.3390/vaccines11020335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959285/
https://www.ncbi.nlm.nih.gov/pubmed/36851213
http://dx.doi.org/10.3390/vaccines11020335

Ejemplares similares